TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
24 hedge funds and large institutions have $23.2M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Holders
24
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$258K | |
| 2 | +$176K | |
| 3 | +$82K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$41K |
| 5 |
Jane Street
New York
|
+$23K |
Top Sellers
| 1 | -$513K | |
| 2 | -$158K | |
| 3 | -$62K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$57K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$27K |